Management of Heart Failure in Italian Outpatients Clinics: Observational Study
- Disease/Condition
- Heart Failure
- Drug/Device/Intervention
- Data collection
- Study type
- Observational
- Intervention type
- other
- Primary sponsor
- Federico II University
- Location
- Napoli, Italy
- Phase
- N/A
- Start date
- Mar 01, 2023
- End date
- Feb 01, 2025
- Enrollment
- 4000 participants
HF treatment adherence according to the most recent European Guidelines
OPTIMA-HF is an observational, cross-sectional, multicenter, real-life study conducted in two
 different clinical settings: HF outpatients' clinics of Italian University Hospitals and
 territorial Cardiology outpatients' services.
 
 Aim of the Optimization of Therapy in the Italian Management of Heart Failure [OpTIMa-HF]
 Registry is to collect data on HF patients followed in different Italian outpatients'
 settings to describe the current Italian population of HF patients, in terms of demographic
 characteristics and disease features, with a specific focus on guideline-directed medical
 therapy (GDMT) prescription, assessing its improvement after educational activities. In the
 present analysis we report the baseline data on the general enrolled population with a
 specific focus on HFrEF treatment adherence and prescription rates, according to the most
 recent European Guidelines.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06287164
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06287164 through Pure Global AI's free database. This phase not specified trial is sponsored by Federico II University and is currently Recruiting. The study focuses on Heart Failure. Target enrollment is 4000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.